Merck (NYSE:MRK) on Tuesday reported second-quarter earnings and revenue that beat and missed analyst expectations, respectively, while narrowing its outlook for the year.

According to economists, this will likely happen at the expense of U.S. consumers, who are expected to bear the brunt of the ...

Chart Industries and Flowserve recently agreed to merge in an all-stock deal. The two companies outlined significant revenue and cost synergies. Strangely, both bargain-priced stocks fell after ...

Now Chart needs to focus on extracting expected cost synergies—$175 million one year after close and $250 million by three years after close, plus expected revenue synergies of $350 million over ...

GE Aerospace ( GE 1.28%) stock trades up more than 60% year to date, and it's understandable if investors are starting to ...

BlackLine, Inc. faces slowing revenue growth, rising SG&A costs, and headwinds such as forex challenges. Read more about BL's strategic moves and valuation insights.

Chart Industries has historically focused on keeping leverage below 3 times debt/EBITDA, reflecting the cyclicality and order lumpiness of many of its end markets. We think this is reasonable ...

Using VISION, this health system increased revenue opportunities by 80%, achieving $500-$600 per chart while reviewing fewer cases. These results underscore how hospitals can streamline operations ...

These costs will grow $503.1 million next fiscal year, which outpaces the nearly $500 million in revenue growth both the administration and the legislature’s nonpartisan Office of Fiscal ...